(Q36235520)

12 August 2017

1 reference

title

Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management (English)

1 reference

12 August 2017

1 reference

2

Elan D Louis

1 reference

12 August 2017

Fred Rincon

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Expert Opinion on Drug Safety

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

899-913

1 reference

Clinical Subtypes of Essential Tremor

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Essential tremor in Rochester, Minnesota: a 45-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Mapping of a familial essential tremor gene, FET1, to chromosome 3q13

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Genetic heterogeneity in autosomal dominant essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Elevation of blood beta-carboline alkaloids in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Disability in essential tremor: effect of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Personality in essential tremor: further evidence of non-motor manifestations of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Change in the concentrations of amino acids in cisternal CSF of patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Preliminary report: activation of the cerebellum in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A positron emission tomography study of cerebral activation associated with essential and writing tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Activation mapping in essential tremor with functional magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Ethanol effects on harmaline-induced tremor and increase of cerebellar cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

beta-Adrenoreceptor antagonists in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Phenylethylmalonamide in essential tremor. A double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Efficacy of primidone in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Primidone in essential tremor of the hands and head: a double blind controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Double-blind comparison of primidone and phenobarbital in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Low doses of topiramate are effective in essential tremor: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Double-blind controlled trial of gabapentin in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Efficacy of alprazolam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

The effect of theophylline on essential tremor: the possible role of GABA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Effect of the beta adrenergic blocking agent propranolol on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Time course of a single oral dose of propranolol in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Metoprolol and propranolol in essential tremor: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Clonidine in essential tremor: preliminary observations from an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Mirtazapine in essential tremor: A double‐blind, placebo‐controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Olanzapine efficacy in the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

The emerging role of clozapine in the treatment of movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Flunarizine- and cinnarizine-induced extrapyramidal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Treatment of essential tremor with methazolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Pilot trial of 1-octanol in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Antiepileptic drug therapy for adults: when to initiate and how to choose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Zonisamide: newer antiepileptic agent with multiple mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

The effect of levetiracetam on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A double-blind trial of isoniazid for essential tremor and other action tremors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Therapeutic uses of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Botulinum toxin treatment of tremors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Long-term follow-up results of selective VIM-thalamotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Stereotactic thalamotomy in the treatment of essential tremor of the upper extremity: reassessment including a blinded measure of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Multicentre European study of thalamic stimulation in essential tremor: a six year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Reduction in voice tremor under thalamic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Multicentre European study of thalamic stimulation in parkinsonian and essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

Red nuclear and cerebellar but no olivary activation associated with essential tremor: A positron emission tomoraphic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.899

21 January 2018

Identifiers

DOI

10.1517/14740338.4.5.899

1 reference

12 August 2017

1 reference